UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exenatide (Exendin-4) Improves Insulin Sensitivity and β-Cell Mass in Insulin-Resistant Obese fa/fa Zucker Rats Independent of Glycemia and Body Weight

Endocrinology (Philadelphia), 2005-04, Vol.146 (4), p.2069-2076

2005

Volltextzugriff (PDF)

Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes

EBioMedicine, 2020-05, Vol.55, p.102759-102759, Article 102759

2020

Volltextzugriff (PDF)

Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes

American journal of physiology: endocrinology and metabolism, 2012-01, Vol.302 (1), p.E68-E76

2012

Volltextzugriff (PDF)

Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial

BMC gastroenterology, 2018-01, Vol.18 (1), p.3-17, Article 3

2018

Volltextzugriff (PDF)

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents

American journal of physiology: endocrinology and metabolism, 2010-12, Vol.299 (6), p.E1076-E1086

2010

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration

International journal of pharmaceutics, 2008-05, Vol.356 (1), p.231-238

2008

Volltextzugriff (PDF)

Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta)

Diabetes (New York, N.Y.), 1999-05, Vol.48 (5), p.1026-1034

1999

Volltextzugriff (PDF)

Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybrids

PloS one, 2013-10, Vol.8 (10), p.e78154-e78154

2013

Volltextzugriff (PDF)

Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187

Regulatory peptides, 2006-12, Vol.137 (3), p.121-127

2006

Volltextzugriff (PDF)

Su1944 INTRARECTAL ADMINISTRATION OF CONJUGATED BILE ACIDS REDUCES FOOD INTAKE, REDUCES WEIGHT, AND INCREASES GLP-1 IN RODENTS AND EX VIVO HUMAN COLON

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-879-S-879

2024

Volltextzugriff (PDF)

Biological activity of AC3174, a peptide analog of exendin-4

Regulatory peptides, 2007-06, Vol.141 (1), p.113-119

2007

Volltextzugriff (PDF)

Effects of Ileo-Colonic Delivery of Conjugated Bile Acids on Glucose Metabolism, GLP-1, and Body Weight in Patients with Obesity and Type 2 Diabetes Mellitus—A Randomized Controlled Trial

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats

Diabetes (New York, N.Y.), 1998-01, Vol.47 (1), p.93-97

1998

Volltextzugriff (PDF)

446 – Modulation of Bile Acids Pathway in Obesity and Type 2 Diabetes

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-93-S-93

2019

Volltextzugriff (PDF)

Dose-response for inhibition by amylin of cholecystokinin-stimulated secretion of amylase and lipase in rats

Regulatory peptides, 2005-08, Vol.130 (1), p.19-26

2005

Volltextzugriff (PDF)

PYY[3-36] Administration Decreases the Respiratory Quotient and Reduces Adiposity in Diet-Induced Obese Mice

The Journal of nutrition, 2006, Vol.136 (1), p.195-201

2006

Volltextzugriff (PDF)

Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes

American journal of physiology: endocrinology and metabolism, 2012, Vol.65 (1)

2012

Volltextzugriff (PDF)

Amylin secretion from the perfused pancreas: Dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats

Biochemical and biophysical research communications, 1991-10, Vol.180 (2), p.782-789

1991

Volltextzugriff (PDF)

Acute Experimental Pancreatitis in Rats Is Ameliorated by Treatment with Pramlintide, a Synthetic Analogue of the β-Cell Hormone Amylin: 189

The American journal of gastroenterology, 2007-09, Vol.102, p.S185-S186

2007

Volltextzugriff (PDF)

Dose-response for glucagonostatic effect of amylin in rats

Metabolism, clinical and experimental, 1997, Vol.46 (1), p.67-70

1997

Volltextzugriff (PDF)

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents

American journal of physiology: endocrinology and metabolism, 2010, Vol.62 (6)

2010

Volltextzugriff (PDF)

Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight

Endocrinology (Philadelphia), 2005-04, Vol.146 (4), p.2069

2005

Volltextzugriff (PDF)

Exenatide (exendin-4) improves insulin sensitivity and β-cell mass in insulin-resistant obese Falfa zucker rats independent of glycemia and body weight

Endocrinology (Philadelphia), 2005, Vol.146 (4), p.2069-2076

2005

Volltextzugriff (PDF)

PYY[3-36] Administration Decreases the Respiratory Quotient and Reduces Adiposity in Diet-Induced Obese Mice1

The Journal of nutrition, 2006-01, Vol.136 (1), p.195-201

2006

Volltextzugriff (PDF)

Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin

Drug development research, 1996-04, Vol.37 (4), p.231-248

1996

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Animals
(16)
Biological And Medical Sciences
(16)
Male
(16)
Rats
(16)
Fundamental And Applied Biological Sciences. Psychology
(11)
Rats, Sprague-Dawley
(10)
Endocrinology & Metabolism
(9)
Medical Sciences
(9)
Vertebrates: Endocrinology
(9)
Islet Amyloid Polypeptide
(8)
Blood Glucose - Analysis
(7)
Obesity
(7)
Peptides - Pharmacology
(7)
Dose-Response Relationship, Drug
(6)
Mice
(6)
Blood Glucose - Metabolism
(5)
Insulin - Blood
(5)
Physiology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Exenatide (Exendin-4) Improves Insulin Sensitivity and β-Cell Mass in Insulin-Resistant Obese fa/fa Zucker Rats Independent of Glycemia and Body Weight

Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes

Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes

Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents

Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration

Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta)

Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybrids

Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187

Su1944 INTRARECTAL ADMINISTRATION OF CONJUGATED BILE ACIDS REDUCES FOOD INTAKE, REDUCES WEIGHT, AND INCREASES GLP-1 IN RODENTS AND EX VIVO HUMAN COLON

Biological activity of AC3174, a peptide analog of exendin-4

Effects of Ileo-Colonic Delivery of Conjugated Bile Acids on Glucose Metabolism, GLP-1, and Body Weight in Patients with Obesity and Type 2 Diabetes Mellitus—A Randomized Controlled Trial

Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats

446 – Modulation of Bile Acids Pathway in Obesity and Type 2 Diabetes

Dose-response for inhibition by amylin of cholecystokinin-stimulated secretion of amylase and lipase in rats

PYY[3-36] Administration Decreases the Respiratory Quotient and Reduces Adiposity in Diet-Induced Obese Mice

Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes

Amylin secretion from the perfused pancreas: Dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats

Acute Experimental Pancreatitis in Rats Is Ameliorated by Treatment with Pramlintide, a Synthetic Analogue of the β-Cell Hormone Amylin: 189

Dose-response for glucagonostatic effect of amylin in rats

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents

Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight

Exenatide (exendin-4) improves insulin sensitivity and β-cell mass in insulin-resistant obese Falfa zucker rats independent of glycemia and body weight

PYY[3-36] Administration Decreases the Respiratory Quotient and Reduces Adiposity in Diet-Induced Obese Mice1

Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin

Suchergebnisse filtern